Trial ID: | L0868 |
Source ID: | NCT02535195
|
Associated Drug: |
Ginger
|
Title: |
Effect of Ginger Supplement on Non-alcoholic Fatty Liver
|
Acronym: |
--
|
Status: |
Not recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Non-alcoholic Fatty Liver Disease
|
Interventions: |
Dietary Supplement: Ginger supplement;Dietary Supplement: Placebo (starch)
|
Outcome Measures: |
Serum levels of the ALT liver enzyme;Serum levels of the AST liver enzymecontrolled attenuation parameter(CAP) score
|
Sponsor/Collaborators: |
Dr Azita Hekmatdoost
|
Gender: |
All
|
Age: |
18 Years70 Years
|
Phases: |
Phase 2/Phase 3
|
Enrollment: |
60
|
Study Type: |
Interventional
|
Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
Start Date: |
24/08/2015
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
7 September 2015
|
Locations: |
--
|
URL: |
https://clinicaltrials.gov/show/NCT02535195
|